Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideBSXBoston Scientific
FinDog View：Neutral
TMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | BSX | TMO |
|---|
| Close | 41.98 | 697.00 |
| Market Cap | $61.1B | $258B |
| 1M | −3.83% | +3.25% |
| P/E (TTM) | 16.8 | 36.4 |
| Forward P/E | 13.2 | 24.6 |
| P/E 5-Yr Percentile | 0 | 78 |
| P/S | 3.0 | 5.4 |
| P/B | 2.5 | 4.7 |
| Dividend Yield | — | 0.29% |
| Latest Quarter Revenue | $5.4B | $12.1B |
| Revenue YoY | +7.5% | +9.1% |
| Gross Margin | 70.7% | — |
| Latest Quarter EPS | 0.61 | 4.64 |
| Avg Post-Earnings Move | ±1.5% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | — | 1.82% |
| 90-Day Net Insider Buying | +$9.5M | −$40.3M |
BSX · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
